Search

Displaying results 7391 - 7400 of 8468 in total
  1. Drug

    IR501

    go.drugbank.com/drugs/DB06464
    Experimental

    It was last known to be in phase III clinical trials.

  2. Drug

    Isoquercetin

    go.drugbank.com/drugs/DB12665
    Investigational

    Isoquercetin has been used in trials studying the treatment of Kidney Cancer, Renal cell carcinoma, Advanced Renal Cell Carcinoma, Thromboembolism of Vein in Pancreatic Cancer, and Thromboembolism of Vein

  3. Drug

    RGX-111

    go.drugbank.com/drugs/DB17632
    Investigational

    Developed by REGENXBIO Inc., it was investigated for the treatment of mucopolysaccharidosis Type I (MPS I).[L46666]

  4. Drug

    Zilovertamab vedotin

    go.drugbank.com/drugs/DB18457
    Investigational

    Zilovertamab vedotin is an Antibody-drug conjugate (ADC) comprising an anti-ROR1 monoclonal antibody (UC-961), a proteolytically cleavable maleimidocaproyl-valine-citrulline-para-aminobenzoate linker (mc-vc-PAB

  5. Drug

    Ambasilide

    go.drugbank.com/drugs/DB19463
    Experimental

    Ambasilide has a monoisotopic molecular weight of 335.2 Da.

  6. Drug

    Bitipazone

    go.drugbank.com/drugs/DB19941
    Experimental

    Bitipazone has a monoisotopic molecular weight of 454.27 Da.

  7. Drug

    Sedecamycin

    go.drugbank.com/drugs/DB21342
    Experimental

    Sedecamycin has a monoisotopic molecular weight of 501.24 Da.

  8. Drug

    Bicozamycin

    go.drugbank.com/drugs/DB20821
    Experimental

    Bicozamycin has a monoisotopic molecular weight of 302.11 Da.

  9. Drug

    Imitrodast

    go.drugbank.com/drugs/DB20840
    Experimental

    Imitrodast has a monoisotopic molecular weight of 260.06 Da.

  10. Drug

    Rotamicillin

    go.drugbank.com/drugs/DB20844
    Experimental

    Rotamicillin has a monoisotopic molecular weight of 549.2 Da.